Canine GM2-Gangliosidosis: Chemical and Enzymatic Features
GM2-gangliosidosis in animals has been observed in cat, dog and swine.1–4 In 1968, McGrath et al. found a new strain of GM2-gangliosidosis in male German short hair pointer dog which had shown signs of progressive neural dysfunction. Onset of the disease was 10–11 months. Clinical signs initiated by a deterioration of his previously keen response to a whistle, included in sequence: incoordination and postual difficulties, progressive impairment of hearing and vision, psychic changes simulating idiocy, terminal convulsions and prostration. Histological observations showed typical ballooning of the cell bodies of many neurons throughout the nervous system. The intracyto-plasmic materials was Sudan black B and PAS positive. Electron microscopic examination revealed typical MCB as found in human Tay-Sachs disease.4 Clinical and pathological features in dog GM2-gangliosidosis appear to be similar to human Tay-Sachs disease. Brief biochemical features of canine GM2-gangliosidosis were previously reported by Autilio-Gambetti. The present report concerns more detail on chemical and enzymatic analysis in tissues of canine GM2-gangliosidosis.
KeywordsCellulose Hydrolysis Electrophoresis Fractionation Polyacrylamide
Unable to display preview. Download preview PDF.
- 4.J. H. McGrath, A. M. Kelly, L. Autilio-Gambetti, and S. A. Steinberg, Nervous system: Storage diseases in dogs and cats, in: “International Encyclopedia of Psychiatry, Psychology, Psychoanalysis and Neurology,” Vol. 8, B. B. Wolman, ed., Human Sciences Press, New York (1977).Google Scholar
- 6.K. Suzuki, The pattern of mammalian brain gangliosides. III. Regional and developmental differences, J. Neurochem. 11:169 (1965).Google Scholar
- 9.Y.-T. Li, M. J. King, and S.-C. Li, Enzymic degradation of gangliosides, In: “Structure and Function of Gangliosides,” Vol. 125, p. 93, Plenum Press, New York (1980).Google Scholar